Allergy Therapeutics PLC Result of AGM (1689G)
November 18 2015 - 6:23AM
UK Regulatory
TIDMAGY
RNS Number : 1689G
Allergy Therapeutics PLC
18 November 2015
18 November 2015
Allergy Therapeutics plc
("Allergy Therapeutics" or the 'Company")
Result of Annual General Meeting
Allergy Therapeutics, the fully integrated specialty
pharmaceutical company specialising in allergy vaccines, announces
that at the Annual General Meeting held today, all the resolutions
put to that meeting were duly passed.
For further information:
Allergy Therapeutics +44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
Panmure Gordon +44 (0) 20 7886 2500
Freddy Crossley / Peter Steel / Duncan Monteith,
Corporate Finance
Tom Salvesen, Corporate Broking
FTI Consulting +44 (0) 20 3727 1000
Simon Conway / Mo Noonan / Victoria Foster
Mitchell
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company
focused on allergy vaccination. It has a growing business achieving
revenue in the last financial year of GBP43 million mainly in
Europe through its own sales and marketing infrastructure and
further afield through distributors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGFFEFEAFISEEF
(END) Dow Jones Newswires
November 18, 2015 07:23 ET (12:23 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024